Blog

T cells

Building CGT’s Clinical Trial Potential: PRA’s Partnership with Cell and Gene Therapy Supply Chain Software Leader Vineti

Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness…

Read More
June 16, 2020

Announcing our new enterprise-grade Alliance Network — and a collaboration with Mavens — to further industrialize cell and gene therapies

Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach...

June 8, 2020

Team Vineti stands in solidarity with the Black community: Black Lives Matter

Our company was founded in 2016 to bring life to the following vision: “Vineti works to create a world where individualized,...

May 29, 2020

Amy DuRoss selected for San Francisco Business Times’ Most Influential Women of 2020

Today, we’re proud to congratulate our CEO and Co-founder, Amy DuRoss, for her selection to the prestigious San Francisco Business Times’...

May 28, 2020

Cell and gene therapy — a dose of good news

Cancer, serious genetic disorders, and other pressing health conditions never stop. Neither does cell and gene therapy. And that’s great...

May 20, 2020

Cardinal Health and Vineti announce collaboration to deliver integrated commercial and logistics solutions to cell and gene therapy manufacturers

DUBLIN, OHIO and SAN FRANCISCO, CA – May 20, 2020 — Cardinal Health and Vineti Inc. today announced a collaboration to...

May 5, 2020

Vineti announces new executive team members

Today, Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, is very pleased to share...

April 14, 2020

Vineti’s four-year anniversary

Happy four-year anniversary Vineti! We are proud to announce that our team has crossed another company milestone: April 10th marked our...

April 2, 2020

Advanced therapies in the COVID-19 pandemic: five guidelines for moving forward

The COVID-19 pandemic presents all of us with a dynamic, disruptive challenge unlike anything most of us have experienced in...

March 18, 2020

Quality Management Systems for advanced therapies, Part 5: what does a successful QMS look like in advanced therapies?

Note: this post is the fifth, and final post, in a five-part series on Quality Management Systems (including cGMP and...

March 11, 2020

Quality Management Systems for advanced therapies, Part 4: practical tips for de-risking the critical risks in the advanced therapy supply chain

Note: this post is the fourth in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

March 9, 2020

Q&A: five questions for Phil Calvin

Today, Vineti is thrilled to announce that Phil Calvin has joined Vineti as our Chief Technology Officer. A veteran technology executive at...

March 3, 2020

Quality Management Systems for advanced therapies, Part 3: a risk based approach – what does this mean for advanced therapies?

Note: this post is the third in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...